← FDA DRUG APPROVALS

FDA ANDA · ANDA071144

IBUPROFEN

Sponsor: ANI PHARMS

APPLICATION
ANDA071144
TYPE
ANDA
ORIGINAL APPROVAL
1987-01-20
LATEST ACTION
1997-05-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

IBUPROFENDiscontinued
IBUPROFEN 200MG · TABLET · ORAL

Approval history

1997-05-05Manufacturing (CMC) · Supplement 20AP
1992-12-16Manufacturing (CMC) · Supplement 3AP
1992-12-16Labeling · Supplement 1AP
1992-12-16Manufacturing (CMC) · Supplement 2AP
1990-12-07Manufacturing (CMC) · Supplement 12AP
1990-01-08Manufacturing (CMC) · Supplement 14AP
1989-04-25Labeling · Supplement 13AP
1989-01-11Manufacturing (CMC) · Supplement 11AP
1988-07-08Manufacturing (CMC) · Supplement 5AP
1988-07-08Labeling · Supplement 4AP
1988-06-30Manufacturing (CMC) · Supplement 9AP
1988-06-30Manufacturing (CMC) · Supplement 7AP
1988-06-30Manufacturing (CMC) · Supplement 8AP
1988-04-06Manufacturing (CMC) · Supplement 6AP
1987-01-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →